Director Jorey Chernett filed a Form 4 with the SEC on November 2, 2026, reporting the open-market purchase of 18,000 shares of Neuronetics, Inc. common stock on October 30, 2026.

Key Highlights

  • Reporting person: Jorey Chernett, listed as a Director of Neuronetics, Inc.
  • Transaction: Purchase (transaction code P) of 18,000 shares of common stock on October 30, 2026.
  • Price paid: $2.27 per share, according to the filing.
  • Resulting ownership: Chernett directly beneficially owned 10,620,988 shares following the transaction, per the filing.
  • No derivative securities: Table II of the filing reports no derivative security transactions.

Chernett's October 2026 Open-Market Purchase of Neuronetics Common Stock

According to the Form 4 filed with the SEC on November 2, 2026, Jorey Chernett, a director of Neuronetics, Inc. (NASDAQ:STIM), acquired 18,000 shares of the company's common stock on October 30, 2026. The filing records the transaction under code "P," indicating an open-market purchase, at a price of $2.27 per share.

Following the reported transaction, the filing states that Chernett directly beneficially owned 10,620,988 shares of Neuronetics common stock. The ownership is recorded as direct (D) in the filing, and no indirect beneficial ownership or derivative securities activity was reported in Table II.

The filing was signed by Jorey Chernett on November 2, 2026. No box was checked to indicate the transaction was made pursuant to a Rule 10b5-1(c) plan, and no amendment date was provided, indicating this is an original filing.

What Was Disclosed

Jorey Chernett, a director of Neuronetics, Inc., reported the purchase of 18,000 shares of common stock at $2.27 per share on October 30, 2026, bringing directly held beneficial ownership to 10,620,988 shares, as disclosed in a Form 4 filed November 2, 2026.